New insider activity at Viemed Healthcare ( (VMD) ) has taken place on March 18, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Timothy Smokoff has recently sold 11,865 shares of Viemed Healthcare stock, amounting to a total transaction value of $91,363.
Recent Updates on VMD stock
Viemed Healthcare has recently disclosed a new risk related to increased costs and management demands following its loss of status as a smaller reporting and emerging growth company. This change requires expanded disclosure obligations, which could elevate legal and financial compliance costs and potentially impact the company’s stock price if not met timely. Despite these challenges, Viemed reported record-breaking financial results for 2024, with a 20% increase in Q4 net revenue and a 23% increase for the full year, driven by growth in its vent and sleep business segments. The company achieved its eighth consecutive year of positive net income, with strong cash flow and a solid balance sheet. Looking forward, Viemed projects continued revenue growth in 2025, supported by strategic initiatives such as expanding its sales force and exploring M&A opportunities. The company’s positive outlook is tempered by challenges like declining EBITDA margins and high capital expenditures, primarily due to ventilator purchases.
More about Viemed Healthcare
YTD Price Performance: -6.89%
Average Trading Volume: 116,096
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $299.2M